Potential for recovery after extremely prolonged VV-ECMO support in well-selected severe COVID-19 patients: a retrospective cohort study

Jean-Marc de Walque,Christophe de Terwangne,Raphaël Jungers,Sophie Pierard,Christophe Beauloye,Fatima Laarbaui,Melanie Dechamps,Luc Marie Jacquet
DOI: https://doi.org/10.1186/s12890-023-02836-3
IF: 3.1
2024-01-10
BMC Pulmonary Medicine
Abstract:VenoVenous ExtraCorporeal Membrane Oxygenation (VV-ECMO) has been widely used as supportive therapy for severe respiratory failure related to Acute Respiratory Distress Syndrome (ARDS) due to coronavirus 2019 (COVID-19). Only a few data describe the maximum time under VV-ECMO during which pulmonary recovery remains possible. The main objective of this study is to describe the outcomes of prolonged VV-ECMO in patients with COVID-19-related ARDS.
respiratory system
What problem does this paper attempt to address?